Genus plc (LSE: GNS), the Basingstoke-headquartered global animal genetics company, issued an AGM trading update on 18 November 2026 covering the four months ended 31 October 2026. The Group confirmed that full-year FY27 adjusted profit before tax in constant currency is expected to be in line with current market expectations, with consensus estimates ranging from £91.0m to £94.5m based on 13 analyst estimates. However, depreciation of the Brazilian real and Mexican peso is now forecast to create a £3m to £4m adverse currency impact for the year, assuming exchange rates remain at current levels.

Key Points

  • Genus plc (GNS) — world-leading animal genetics company operating across dairy, beef and pork sectors in over 75 countries
  • FY27 adjusted profit before tax in constant currency expected in line with market consensus; second half weighting maintained as previously guided
  • Currency headwinds of £3m–£4m anticipated for the full year; consensus adjusted PBT range is £91.0m–£94.5m, average midpoint £93.3m
  • Investors will be watching the ABS division's second-half recovery and the interim results due on 25 February 2027

PIC Division Delivers Resilience Through Royalty Model Amid Tough Agricultural Backdrop

Genus's PIC business, which sells superior pig genetics under a royalty-based model across global pork supply chains, delivered resilient trading during the period despite challenging end-markets for its customers. The announcement attributes this performance to the structural strength of the royalty model, strong product performance, and long-standing customer relationships. PIC operates within Genus's broader competitive framework, which is underpinned by proprietary breeding lines, biotechnology, and an extensive global distribution network. The PRRS Resistant Pig, described in the announcement as a market-leading gene-editing innovation, remains subject to regulatory approval before commercial launch in the porcine sector.

ABS Cattle Division Faces Headwinds as Low Global Dairy Prices Weigh on Customer Profitability

Trading in the ABS division, which covers dairy and beef cattle genetics sold across more than 75 countries, has been challenging during the period. The announcement states that persistently low global dairy prices have continued to weigh on customer profitability, directly affecting demand for ABS products including semen, embryos, and breeding animals. Management expects a material improvement in ABS performance during the second half of FY27, supported by commercial and operational initiatives. The company did not disclose the specific nature of those initiatives in the announcement, nor provide divisional revenue or volume figures for the period under review.

Brazilian Real and Mexican Peso Depreciation to Create £3m–£4m Currency Drag for Full Year

Genus operates in over 25 countries across six continents, with meaningful exposure to Latin American markets, making currency movements a material risk. The depreciation of the Brazilian real and Mexican peso against sterling during the four-month period is now expected to generate an adverse currency impact of between £3m and £4m for the full financial year, assuming current exchange rates persist. This headwind sits outside the constant-currency profit guidance already issued and represents a company-specific risk for investors monitoring full-year reported earnings. Genus's interim results for the six months ending 31 December 2026 are scheduled for release on 25 February 2027.